Total Payments
$36,312
2024 Payments
$18,516
Companies
46
Transactions
898
Medicare Patients
1,539
Medicare Billing
$156,209
Payment Breakdown by Category
Food & Beverage$18,685 (51.5%)
Other$17,199 (47.4%)
Education$362.86 (1.0%)
Gifts$65.75 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,685 | 872 | 51.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,199 | 10 | 47.4% |
| Education | $362.86 | 13 | 1.0% |
| Gift | $65.75 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $19,297 | 89 | $0 (2024) |
| Alkermes, Inc. | $1,588 | 61 | $0 (2024) |
| ABBVIE INC. | $1,503 | 91 | $0 (2024) |
| Validus Pharmaceuticals LLC | $1,301 | 18 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $1,300 | 76 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $1,271 | 45 | $0 (2024) |
| Allergan, Inc. | $889.17 | 64 | $0 (2020) |
| Lundbeck LLC | $871.23 | 49 | $0 (2024) |
| Axsome Therapeutics, Inc. | $791.91 | 17 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $700.40 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,516 | 107 | Otsuka America Pharmaceutical, Inc. ($16,479) |
| 2023 | $3,939 | 125 | Otsuka America Pharmaceutical, Inc. ($1,131) |
| 2022 | $2,789 | 132 | Neurocrine Biosciences, Inc. ($381.24) |
| 2021 | $2,684 | 92 | Validus Pharmaceuticals LLC ($914.68) |
| 2020 | $1,153 | 72 | Sunovion Pharmaceuticals Inc. ($202.90) |
| 2019 | $2,521 | 121 | Otsuka America Pharmaceutical, Inc. ($530.75) |
| 2018 | $2,255 | 128 | Sunovion Pharmaceuticals Inc. ($360.84) |
| 2017 | $2,456 | 121 | Otsuka America Pharmaceutical, Inc. ($600.85) |
All Payment Transactions
898 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $28.55 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/12/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Neuropsychiatry | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,106.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Neuroscience | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,106.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $54.52 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Opioid Use Disorder | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,106.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: CNS | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $18.70 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Neuropsychiatry | ||||||
| 10/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,106.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 283 | 426 | $97,020 | $34,779 |
| 2022 | 6 | 362 | 605 | $94,430 | $33,389 |
| 2021 | 6 | 499 | 822 | $129,190 | $46,948 |
| 2020 | 5 | 395 | 889 | $129,220 | $41,094 |
Total Patients
1,539
Total Services
2,742
Medicare Billing
$156,209
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 175 | $42,000 | $14,363 | 34.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 75 | $21,750 | $9,786 | 45.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 22 | 22 | $7,260 | $2,806 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 49 | $7,350 | $2,633 | 35.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 12 | 12 | $5,060 | $1,587 | 31.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 24 | 31 | $4,650 | $1,221 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 24 | $4,200 | $1,001 | 23.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 11 | 15 | $1,875 | $815.29 | 43.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 23 | $2,875 | $565.76 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 277 | $42,125 | $14,820 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 85 | $20,530 | $7,934 | 38.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 71 | 119 | $17,850 | $5,606 | 31.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 20 | 20 | $6,125 | $2,823 | 46.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 41 | 56 | $6,600 | $1,728 | 26.2% |
| 90785 | Psychiatric services complicated by communication factor | Office | 2022 | 31 | 48 | $1,200 | $478.09 | 39.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 164 | $36,640 | $13,202 | 36.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 135 | 217 | $33,575 | $13,163 | 39.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 111 | 219 | $32,850 | $10,479 | 31.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 82 | 120 | $14,500 | $4,663 | 32.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 33 | 33 | $9,900 | $4,652 | 47.0% |
| 90785 | Interactive complexity | Office | 2021 | 33 | 69 | $1,725 | $788.69 | 45.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 184 | 518 | $77,635 | $22,904 | 29.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 110 | 230 | $32,750 | $11,657 | 35.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 43 | 43 | $12,625 | $4,621 | 36.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 28 | 47 | $5,015 | $1,343 | 26.8% |
About Dr. Gerald Plovsky, MD
Dr. Gerald Plovsky, MD is a Psychiatry healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982641858.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Plovsky, MD has received a total of $36,312 in payments from pharmaceutical and medical device companies, with $18,516 received in 2024. These payments were reported across 898 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($18,685).
As a Medicare-enrolled provider, Plovsky has provided services to 1,539 Medicare beneficiaries, totaling 2,742 services with total Medicare billing of $156,209. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Greensboro, NC
- Active Since 06/01/2006
- Last Updated 04/13/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1982641858
Products in Payments
- REXULTI (Drug) $19,029
- VRAYLAR (Drug) $2,373
- Equetro (Drug) $1,300
- LATUDA (Drug) $1,300
- INGREZZA (Drug) $1,271
- ABILIFY MAINTENA (Drug) $943.63
- NUPLAZID (Drug) $700.40
- ARISTADA (Drug) $680.97
- Auvelity (Drug) $628.98
- CAPLYTA (Drug) $585.38
- SPRAVATO (Drug) $467.34
- Dyanavel XR (Drug) $405.89
- NUEDEXTA (Drug) $385.48
- APLENZIN (Drug) $309.13
- AUSTEDO (Drug) $288.99
- TRINTELLIX (Drug) $277.87
- Vivitrol 380 mg (Drug) $266.50
- Azstarys (Drug) $265.02
- LYBALVI (Drug) $247.33
- HETLIOZ (Drug) $245.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Greensboro
Dr. Parish Mckinney, Md, MD
Psychiatry — Payments: $143,648
Psychiatry $143,648
Dr. Kenneth Headen, Md, MD
Psychiatry — Payments: $14,366
Psychiatry $14,366
Dr. Rupinder Kaur, M.d, M.D
Psychiatry — Payments: $13,042
Psychiatry $13,042
Carey Cottle, Md, MD
Psychiatry — Payments: $10,156
Psychiatry $10,156
Dr. Scott Cunningham, Md, MD
Psychiatry — Payments: $5,932
Psychiatry $5,932
Dr. Archana Kumar, Md, MD
Psychiatry — Payments: $3,814
Psychiatry $3,814